Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

KB407 utilizes a replication-defective HSV-1 vector to deliver full-length CFTR to the airway epithelium. The interim readout ...

Here’s the latest company planning for gene-edited babies The news: A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...

Taysha Gene Therapies Inc. (NASDAQ:TSHA) is a clinical-stage biotechnology company that develops and commercializes ...

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Biomarin Pharmaceutical Inc. (($BMRN)) announced an update on their ongoing clinical study. BioMarin Pharmaceutical Inc. is conducting a long-term ...

Microorganisms produce a wide variety of natural products that can be used as active ingredients to treat diseases such as infections or cancer. The blueprints for these molecules can be found in the ...

Penn Gene Therapy Program Director James Wilson will depart the University, and the functions and assets of Penn Medicine’s Gene Therapy Program will be transferred to two new for-profit companies: ...